We used Ki67 staining to further confirm the differences between treatments in tumor proliferation (Fig. 4G), and Western blot showed that TBOPP abolished metformin-mediated RAC1 activation in the NRASG12V/shP53-induced orthotopic HCC model (Fig. 4H). This evidence concerns the gene MKI67 and hepatocellular carcinoma.